ArticlePain reports2026
Pain medication and nerve injuries in upper or lower limb-a Swedish national registry study.
Article in Pain reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Severe symptoms and disability may remain after upper and lower limb nerve injuries with an additional risk of persistent pain and consumption of pain medication. Objectives: To examine whether upper and lower limb nerve injuries, potentially causes of pain, are associated with risk of using pain medication. Methods: Drug use at an individual level was analysed in a large Swedish record-linkage database covering 6,579,612 individuals (age ≥18 years; first-ever nonsurgically [n = 5,249] and surgically treated [n = 3,669] upper limb and nonsurgically [n = 1,260] and surgically treated [n = 14] lower limb nerve injuries; International Classification of Diseases, 10th version and NOMESCO codes; 90-day washout period after surgery). Associations were expressed as relative risks (95% confidence interval), unadjusted and adjusted for demographic and socioeconomic factors. Results: Adjusted risk for use of pain medications during the first year after diagnosis and/or surgery was higher in upper (4.85 [4.51-5.23]) and lower (5.60 [4.85-6.48]) limb nerve injuries than in the general population and was considerably lower if surgery was performed (0.31 [0.26-0.36]). Risk during the second year declined but remained. Consumption of pain medication during the first year increased risk of use during the second year (11.45 [11.35-11.56]). Older age, female sex, living alone, low-middle income, and immigrant status were associated with a higher risk. Conclusion: Upper and lower limb nerve injuries substantially increase the risk of long-term use of pain medication. Surgical treatment reduces the risk during the first year, indicating the relevance of appropriate surgical treatment, but demographic and socioeconomic disparities remain essential determinants. Notably, previous consumption during the first year increases the risk of consumption in the second year. Despite being a third-line therapy for neuropathic pain, opioids accounted for many prescriptions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.